Outgoing OGD Director Outlines Accomplishments During His Tenure

Gregory Geba highlights the strides the Office of Generic Drugs made in implementing the generic drug user fee program in his resignation announcement.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America